Evaluation of new iron chelators and their therapeutic potential

被引:48
作者
Aouad, F [1 ]
Florence, A [1 ]
Zhang, Y [1 ]
Collins, F [1 ]
Henry, C [1 ]
Ward, RJ [1 ]
Crichton, RR [1 ]
机构
[1] Univ Catholique Louvain, Unite Biochim, B-1348 Louvain, Belgium
关键词
homeostasis; metal ions; chelation;
D O I
10.1016/S0020-1693(02)01040-X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
One of the most important challenges for biological inorganic chemistry is to understand metal ion homeostasis, particularly since we are becoming increasingly aware that its disequilibrium is at the basis of a large number of clinical disorders. It is, therefore, also an important objective of our research to seek solutions, which can alleviate the consequences of the perturbation of the homeostasis of key metal ions within cells, tissues and organisms. Iron is one of the key metals in biology, for which disorders of homeostasis are implicated in a vast panoply of pathological conditions. We review here the ways in which potential iron chelators can be evaluated, using appropriate in vivo or in vitro screening systems, and discuss their potential applications in the chelation of both iron and aluminium in the treatment of a number of human diseases. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:470 / 480
页数:11
相关论文
共 50 条
[1]  
Abdallah MA, 1991, HDB MICROBIAL IRON C, P139
[2]  
Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239
[3]   O-TRENSOX - A PROMISING WATER-SOLUBLE IRON CHELATOR (BOTH FE-III AND FE-II) POTENTIALLY SUITABLE FOR PLANT NUTRITION AND IRON CHELATION-THERAPY [J].
BARET, P ;
BEGUIN, CG ;
BOUKHALFA, H ;
CARIS, C ;
LAULHERE, JP ;
PIERRE, JL ;
SERRATRICE, G .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (38) :9760-9761
[4]   Desazadesmethyldesferrithiocin analogues as orally effective iron chelators [J].
Bergeron, RJ ;
Wiegand, J ;
Weimar, WR ;
Vinson, JRT ;
Bussenius, J ;
Yao, GW ;
McManis, JS .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (01) :95-108
[5]   STOFFWECHSELPRODUKTE VON ACTINOMYCETEN .22. UBER EISENHALTIGE WACHSTUMSFAKTOREN, DIE SIDERAMINE, UND IHRE ANTAGONISTEN, DIE EISENHALTIGEN ANTIBIOTIKA SIDEROMYCINE [J].
BICKEL, H ;
GAUMANN, E ;
KELLERSCHIERLEIN, W ;
PRELOG, V ;
VISCHER, E ;
WETTSTEIN, A ;
ZAHNER, H .
EXPERIENTIA, 1960, 16 (04) :129-133
[6]   The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation [J].
Breuer, W ;
Ronson, A ;
Slotki, IN ;
Abramov, A ;
Hershko, C ;
Cabantchik, ZI .
BLOOD, 2000, 95 (09) :2975-2982
[7]   Iron chelation therapy in sickle cell disease [J].
Cohen, AR ;
Martin, MB .
SEMINARS IN HEMATOLOGY, 2001, 38 (01) :69-72
[8]   REGIONAL DISTRIBUTION OF IRON AND IRON-REGULATORY PROTEINS IN THE BRAIN IN AGING AND ALZHEIMERS-DISEASE [J].
CONNOR, JR ;
SNYDER, BS ;
BEARD, JL ;
FINE, RE ;
MUFSON, EJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 31 (02) :327-335
[9]  
CRICHTON RR, 2001, INORGANIC BIOCH IRON, P319
[10]  
CRICHTON RR, IN PRESS COORD CHEM